Hetero biaryl derivatives as matrix metalloproteinase inhibitors
US7179822B2 · kind B2 · utility
10Cited by
8References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 5, 2003 |
| Grant date | Feb 20, 2007 |
| Priority date | — |
| Expiry date | May 24, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention provides compounds defined by Formula Iand pharmaceutically acceptable salts thereof,and pharmaceutical compositions comprising a compound of Formula I, or a pharmaceutically acceptable salt thereof, together with a pharmaceutically acceptable carrier, diluent, or excipient. The invention also provides methods of treating osteo- and rheumatoid arthritis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.